These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

Q1 2026 Earnings Call March 13, 2026 11:00 AM EDTCompany ParticipantsDavid Collins - VP & ControllerStuart Miller - ...

Good afternoon, and welcome to Jefferson Capital's Fourth Quarter and Full Year 2025 Conference Call. With us today are David Burton, Founder and Chief Executive Officer; and Christo Realov, Chief ...

Adjusted net loss -- $21 million, a deterioration from the prior quarter's $3 million adjusted net loss, driven mainly by a ...

In Nevada’s Catholic schools, there is only one place where a child with special needs sits beside their classmates, not apart from them. At St. Viator Parish School in central Las Vegas ...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

On the high street in Redcar, there’s a shop selling ornamental animals. These range from an £80 model gorilla to a large blue tit – “slightly damaged” and on sale for £2.

Our results were released this morning in our earnings press release, which can be found on the Investor Relations section of ...

"An ex-friend demanded I throw her a huge surprise 40th birthday party and invite a bunch of (sketchy) people I'd never met. To my house. During the COVID lockdown. While I was dealing with chemo and ...

Major research hospitals and prestigious universities snared a significant share of Philanthropy 50 gifts, but lesser known ...